文献速递神经肿瘤

经蝶术后伽玛刀放射外科治疗侵犯海绵窦的生长激素分泌型垂体腺瘤

Postoperative Gamma Knife Radiosurgery for Cavernous Sinus-Invading Growth Hormone-Secreting Pituitary Adenomas.
PubMed 文献 · World Neurosurg · 2017-11-16

研究纳入30例经蝶手术后仅海绵窦内残留肿瘤并接受伽玛刀放射外科(GKS)的肢端肥大症患者,中位随访47个月。平均肿瘤体积3.7 cm³、边缘剂量26.2 Gy。全部患者影像学肿瘤控制,14例内分泌缓解,2、5、10年缓解率分别为7.1%、43.6%、65.6%。新发垂体功能减退随时间推移常见,4例出现放射性坏死。

要点

  • GKS对经蝶术后海绵窦内残留的生长激素分泌型垂体腺瘤可实现全部影像学肿瘤控制。
  • 14例内分泌缓解,中位缓解时间35个月,2、5、10年缓解率分别为7.1%、43.6%、65.6%。
  • 新发垂体功能减退随时间推移常见,4例出现放射性坏死。

核心结论

  • GKS是经蝶术后海绵窦内残留肿瘤的有效辅助治疗选择。
  • 最大程度手术切除、仅在海绵窦内遗留最小体积残留,可安全充分地递送放射剂量,从而提高缓解可能性。
  • 对海绵窦内肿瘤行GKS时,应考虑新发垂体功能减退和放射性坏死的风险。

研究设计与样本

  • 纳入30例经蝶手术后仅海绵窦内残留肿瘤并接受GKS的患者,GKS后中位随访47个月,定期行激素和影像学检查。

主要发现

  • GKS平均肿瘤体积3.7 cm³、平均边缘剂量26.2 Gy。
  • 全部患者影像学肿瘤控制,未见肿瘤再生长或复发。
  • 14例达到内分泌缓解,从GKS至缓解的中位时间35个月。
  • 2、5、10年缓解率分别为7.1%、43.6%、65.6%。
  • GKS后6个月口服葡萄糖耐量试验(OGTT)中生长激素(GH)谷值下降程度是缓解的统计学显著预测因素;新发垂体功能减退随时间推移常见;4例残留体积相对较大的患者发生放射性坏死。

临床怎么用

  • GKS可作为经蝶术后海绵窦内残留肿瘤的辅助治疗选择。
  • 作者认为最大程度手术切除、仅在海绵窦内遗留最小体积残留,有助于安全充分地递送放射剂量并提高缓解可能性。
  • 作者指出对海绵窦内肿瘤行GKS时应考虑新发垂体功能减退和放射性坏死的风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We aimed to determine the long-term effects of Gamma knife radiosurgery (GKS) on remnants in the cavernous sinus (CS) after transsphenoidal surgery (TSS) for acromegaly and to identify its possible adverse effects. METHODS: Thirty patients who had remnant tumors only inside the CS after TSS and who consequently underwent GKS were included. They were followed for a median period of 47 months after GKS with regular hormonal and radiologic examinations. RESULTS: The mean tumor volume and margin dose irradiated by GKS was 3.7 cm3 and 26.2 Gy, respectively. Radiologic tumor control was identified in all patients, and no tumor regrowth or recurrent tumors were identified. For 14 patients who achieved endocrinologic remission, the median duration from GKS until remission was 35 months. The actuarial rates of remission at 2, 5, and 10 years were 7.1%, 43.6%, and 65.6%, respectively. The degree of decrease in the nadir GH level in the OGTT at 6 months after GKS was a statistically significant predictor of remission. Newly developed hypopituitarism frequently developed in a time-dependent manner. Radiation necrosis developed in 4 patients with relatively large remnant volumes. CONCLUSIONS: GKS is an effective adjuvant treatment option for remnant tumors inside the CS after TSS. Maximal surgical resection, leaving minimal volume of remnants only inside the CS, allows the safe and sufficient delivery of a radiation dose to tumors, thereby increasing the possibility of remission. However, the risk of new hypopituitarism and radiation necrosis should be considered when tumors inside the CS are treated with GKS.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Kim EH, Oh MC, Chang JH, et al. Postoperative Gamma Knife Radiosurgery for Cavernous Sinus-Invading Growth Hormone-Secreting Pituitary Adenomas. World Neurosurg. 2017. PMID: 29155347. doi:10.1016/j.wneu.2017.11.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。